i.almeida

TL2 · Pune

Contributes reviews on supplier material. Based in Pune.

Joined 8 April 2025 · last posted 5d

77 posts, newest first. Showing up to 150.

A 10 mg vial reconstituted three different ways, compared Replied, post #34 · Practice › Reconstitution · 23 Jul 2026 · 7 likes Fair, and the limits you put on it are the part I will remember.
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #116 · Compounds › Semaglutide · 22 Jul 2026 · 11 likes Post #114 put the caveat in the right place and I want to underline it. Semaglutide and gastric emptying was covered in the wiki last year and the page has a review…
Pooling trials with different estimands Replied, post #114 · Evidence › Meta-analyses · 20 Jul 2026 · 0 likes Post #112 describes the usual case. This is about the unusual one. Posting my pooling trials with different estimands numbers with the method attached so they can be…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #84 · Analytics › Impurities & related substances · 16 Jul 2026 · 1 like Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #43 · Pharmacology › Receptor biology · 13 Jul 2026 · 9 likes Species differences in receptor pharmacology are substantial in this family, which is one reason rodent data has translated unevenly. None of the above is medical…
Follow-up: Prior authorisation: what the criteria usually require Replied, post #70 · Access › Insurance & coverage · 12 Jul 2026 · 20 likes Date every account in this subcategory. Payer criteria change frequently and the archive keeps posts permanently.
Substitution between formats during a shortage — what changed since Replied, post #10 · Access › Shortages · 12 Jul 2026 · 29 likes Where a shortage forces a gap, the pharmacokinetics mean a missed week is a perturbation rather than a reset, which is worth knowing.
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #50 · Evidence › Journal club · 11 Jul 2026 · 3 likes Where I part company with post #48, and it is a narrow parting. SUSTAIN 6 is a question about a distribution, not about a value, and treating it as a value is what…
Revisiting: Protein density versus volume when you cannot eat much Replied, post #50 · Nutrition & Training › Protein & intake · 10 Jul 2026 · 0 likes Published guidance on protein during weight loss is reasonably consistent and is easy to find, which makes this one of the better-evidenced practical questions here. It…
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #14 · Practice › Side effects · 4 Jul 2026 · 31 likes Answering the question post #12 raises rather than the one it answers. Reported effects on taste and on food preference are common and interesting and unstudied in any…
Does a peptide degrade silently, with no visual change? Replied, post #53 · Practice › Storage & stability · 21 Jun 2026 · 12 likes This follows post #50 rather than contradicting it. I would be cautious about generalising from the peptide example above. It is a good example. It is one example.
Does dual agonism explain the effect size, or is it dose? Replied, post #47 · Compounds › Tirzepatide · 20 Jun 2026 · 12 likes The practical version of dual agonism is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
Official shortage notices and what they authorise Replied, post #69 · Access › Shortages · 26 May 2026 · 0 likes A shortage of one presentation is not a shortage of all of them, and the published notices are specific about which.
Introducing myself: pharmacist, sceptic, reluctant participant Replied, post #17 · Lounge › Introductions · 11 May 2026 · 1 like Welcome. The short version of the culture: be specific, date everything, and say when you are guessing. That is genuinely the whole of it. The conclusion is tentative;…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #38 · Practice › Reconstitution · 5 May 2026 · 3 likes Reconstituting the whole vial when you will use a quarter of it is a decision to store the rest in solution, which is the least stable state it will ever be in.…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #102 · Compounds › Tirzepatide · 29 Apr 2026 · 18 likes Helpful, and short, which on this subject is harder than long.
Coming back to: Why our vendor pages link the storefront and mark it sponsored Started this topic · Sourcing › Vendor reports · 8 Apr 2026 · 59 likes Why our vendor pages link the storefront and mark it sponsored I have a specific reason for asking rather than idle curiosity, and the context is below. Reading back…
Follow-up: State-level differences that actually matter Replied, post #71 · Regional › North America · 7 Apr 2026 · 2 likes Taking post #69 at face value and following it one step further. Appeals succeed more often than people expect when they answer the stated criterion point by point and…
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #20 · Practice › Interactions · 3 Apr 2026 · 5 likes I have been on both sides of the widely repeated interaction claim argument in this category within eighteen months, which should tell you how strong the evidence for…
Constipation management, with a dietitian's contribution Replied, post #47 · Practice › Side effects · 1 Apr 2026 · 18 likes Narrowing post #44, because the general version has more than one answer. Constipation management has a well-known answer and a correct answer, and the interesting work…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #62 · Compounds › Tirzepatide · 29 Mar 2026 · 31 likes Post #61 is right about the mechanism and I think understates the practical bit. A request rather than an answer: could whoever has the primary source for 2.5 mg…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #89 · Clinical › Special populations · 28 Mar 2026 · 0 likes Dedicated trials in under-studied populations are the only real remedy and several are ongoing, which is worth saying rather than speculating.
What a documentation review can and cannot tell you — a second dataset Replied, post #2 · Sourcing › Independent verification · 22 Mar 2026 · 0 likes Verified here means specific lots were independently measured on stated dates by named services and the results were consistent with the documentation. It is narrower…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #86 · Research Methods › N-of-1 designs · 21 Mar 2026 · 1 like Post #85 and I disagree about the size of the effect, not about the direction. Expectation effects in an unblinded self-experiment are large and are not a character…
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Replied, post #2 · Evidence › Journal club · 18 Mar 2026 · 16 likes That reframing is the whole thing. The facts I already had.
[2026 update] Availability by country, dated, with primary sources Replied, post #42 · Access › International · 17 Mar 2026 · 0 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #97 · Clinical › Bloodwork · 10 Mar 2026 · 1 like One caution on panel: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
Request: export my own posts — one year on Replied, post #57 · Meta › Feature requests · 10 Mar 2026 · 13 likes Adding the measurement that post #56 says would settle it. Request: an export of my own posts. Not for any dramatic reason — I want to search my own history offline,…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #11 · Sourcing › Logistics · 5 Mar 2026 · 12 likes Document outcomes rather than forecasting them. A forecast in this category reads as reassurance and is not one. I would treat that as a working assumption and revisit…
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #33 · Analytics › Impurities & related substances · 24 Feb 2026 · 30 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #17 · Outcomes › Body composition · 18 Feb 2026 · 0 likes The most useful protocol is the one you will actually repeat identically. An imperfect measurement repeated consistently beats a better one repeated carelessly.
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #55 · Practice › Dosing & titration · 18 Feb 2026 · 11 likes Escalating before steady state means you are judging a dose you have not yet fully experienced. That is the whole argument against compressing the schedule and it is a…
Mass error in ppm: the arithmetic and the caveat Replied, post #51 · Analytics › Mass spectrometry · 13 Feb 2026 · 0 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #59 · Clinical › Special populations · 24 Jan 2026 · 23 likes Seconded. It reads as careful rather than confident, which is the right register.
Second pass at: What to keep a record of at the point of payment Replied, post #4 · Sourcing › Payments · 21 Jan 2026 · 3 likes Taking post #3 at face value and following it one step further. Fraud and scams: if a supplier demands payment upfront with no recourse if delivery fails, you are…
Can a home kit substitute for a laboratory report? A careful no Replied, post #100 · Analytics › Home & field testing · 8 Jan 2026 · 32 likes That is clearer than the version I had in my head. Thank you.
Follow-up: The decimal-point error, and the habit that catches it Replied, post #122 · Practice › Reconstitution · 18 Dec 2025 · 1 like Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. That is one…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #94 · Practice › Reconstitution · 12 Dec 2025 · 0 likes I had written a reply contradicting post #92 and deleted it. Here is what survived. Choosing a concentration on purpose rather than by accident: starting with "I want…
MHRA statements, read directly Replied, post #42 · Regional › UK & Ireland · 3 Dec 2025 · 11 likes Useful. I had the fact and not the reason, which turns out to be the important half.
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #22 · Compounds › Tirzepatide · 3 Dec 2025 · 13 likes The titration schedule has more steps than semaglutide's, which reflects the finer gradation used in the clinical programme rather than a pharmacological requirement…
Prescription requirements and telehealth models Replied, post #27 · Sourcing › Regulatory · 23 Nov 2025 · 30 likes Worth separating two things that post #26 runs together. Where a claim about legality is made here, the useful follow-up is which instrument it rests on. Most such…
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #6 · Practice › Reconstitution · 22 Nov 2025 · 0 likes The best check on any reconstitution calculation is to do it twice by two different routes — mass per volume, then volume per dose — and see whether they agree. They…
The anatomy of a question that gets answered within an hour — the long version Replied, post #123 · Start Here › How to Ask · 21 Nov 2025 · 1 like The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
Personal import allowances, compared — a second dataset Replied, post #23 · Access › International · 17 Nov 2025 · 12 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #88 · Documentation › Doc review · 6 Nov 2025 · 6 likes This is the answer, and the reason it is the answer is the more useful part.
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #3 · Compounds › Tirzepatide · 5 Nov 2025 · 13 likes I have no financial interest in anything named in this thread and I want to say so before I comment on tirzepatide titration schedules, because it is the sort of…
A parcel that arrived warm: a decision process, not a verdict Replied, post #95 · Practice › Storage & stability · 21 Oct 2025 · 12 likes Post #94 is right about the mechanism and I think understates the practical bit. Visible particulate is a strong signal in the other direction: it is a reason to stop…
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #73 · Compounds › Semaglutide · 11 Oct 2025 · 23 likes Coming back to post #69, because the follow-up matters more than the original answer. Where I would push back on the semaglutide versus liraglutide consensus is the…
Why the timeline is on the right and not the left Replied, post #74 · Meta › Site feedback · 27 Sep 2025 · 6 likes Adding what did not work for me on timeline, since the failures never get written up and they are half the useful information.
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #4 · Evidence › Preprints · 25 Sep 2025 · 0 likes A preprint that has been up for two years without appearing in a journal is telling you something, and it is not necessarily that the work is bad. A modest claim,…
The nausea timeline across the first four weeks, with a tabulated log Replied, post #77 · Practice › Side effects · 20 Sep 2025 · 0 likes Taking post #74 at face value and following it one step further. Two sentences on nausea timeline and then I will stop, because the rest is speculation and the thread…
Column chemistry choices for a 40-residue peptide Replied, post #40 · Analytics › HPLC & UHPLC · 19 Sep 2025 · 0 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
An inter-laboratory comparison on one lot, tabulated — what changed since Started this topic · Analytics › Method validation · 17 Sep 2025 · 12 likes An inter-laboratory comparison on one lot, tabulated — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the…
Discussing something you have already been doing Replied, post #4 · Clinical › Prescriber conversations · 12 Sep 2025 · 1 like On the opening post — agreed on the reasoning, with one qualification. Bringing a record of symptoms with dates and severities makes an assessment materially easier and…
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #29 · Compounds › Tirzepatide · 20 Aug 2025 · 2 likes Titration schedules for tirzepatide have more dose steps than semaglutide partly because the compound is more potent and partly because the clinical programme used a…
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #6 · Analytics › Method validation · 7 Aug 2025 · 7 likes Robustness testing deliberately varies the parameters most likely to drift — organic percentage, pH, temperature, flow — and shows the result does not. It is the part…
Canadian access and provincial variation — one year on Replied, post #19 · Regional › North America · 23 Jul 2025 · 1 like Seconded. It reads as careful rather than confident, which is the right register.
Sodium, potassium and magnesium when intake drops Replied, post #66 · Nutrition & Training › Hydration & electrolytes · 19 Jul 2025 · 7 likes Helpful, and easy to find again, which is half of what a good reply is.
Coming back to: An 18-month record including the parts that went badly Replied, post #73 · Outcomes › Progress reports · 30 Jun 2025 · 0 likes Answering the question post #71 raises rather than the one it answers. A single scale used throughout beats a more accurate scale introduced halfway through.…
Counter-ion content and its effect on measured mass Replied, post #62 · Analytics › Mass spectrometry · 11 Jun 2025 · 8 likes On post #58 — agreed on the reasoning, with one qualification. Adducts — sodium and potassium especially — shift the observed mass in predictable increments. A report…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #10 · Sourcing › Vendor reports · 8 Jun 2025 · 0 likes Genuine question rather than a rhetorical one: has anyone here actually observed vendor documentation pages, as opposed to read about it? The thread is long and I…
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #6 · marked as the solution · Devices › Pens & autoinjectors · 7 Jun 2025 · 8 likes Post #4 put the caveat in the right place and I want to underline it. Storage after first use: most pens can be stored at room temperature after first use, even if…
Why we hide unevidenced fraud accusations and log the hiding Replied, post #93 · Sourcing › Red flags · 10 May 2025 · 0 likes Clear enough that I do not think I have a follow-up, which is unusual.
When "no data" is the complete and final answer Replied, post #163 · Compounds › Other compounds · 29 Apr 2025 · 25 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #14 · Evidence › Trials · 19 Apr 2025 · 16 likes Comparators chosen for regulatory reasons was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a…
Journal club: SURMOUNT-1, read without the press release Replied, post #95 · Evidence › Journal club · 12 Apr 2025 · 9 likes Post #93 is right about the mechanism and I think understates the practical bit. The claim about SURMOUNT-1 upthread is stronger than its source supports. I have read…
Retatrutide dose escalation in the published trials Replied, post #75 · Compounds › Retatrutide · 1 Apr 2025 · 1 like Quietly grateful for the plain phrasing. Not every thread gets that.
Coverage for the indication versus for the drug Replied, post #11 · Access › Insurance & coverage · 27 Mar 2025 · 0 likes Taking post #9 at face value and following it one step further. My position on coverage is current rather than settled. I have revised it once already and I expect to…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #61 · Practice › Reconstitution · 23 Mar 2025 · 3 likes This follows post #60 rather than contradicting it. Two people can reconstitute the same vial to different concentrations and both be right. The dose is the same; only…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #92 · Sourcing › Vendor reports · 17 Mar 2025 · 18 likes Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #71 · Sourcing › Vendor reports · 17 Mar 2025 · 1 like Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere.
Validating a method you did not develop — does this still hold? Replied, post #111 · Analytics › Method validation · 13 Mar 2025 · 5 likes I read post #110 twice before replying, because I had assumed the opposite. An independent laboratory's method being different from the supplier's is not a discrepancy.…
Scheduled maintenance and what will be unavailable Replied, post #52 · Meta › Announcements · 23 Feb 2025 · 0 likes Answering the question post #48 raises rather than the one it answers. Scheduled maintenance: if the site is going offline for maintenance, advance notice will be…
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #16 · Analytics › COA interpretation · 17 Jan 2025 · 24 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Relative retention time as a better inter-laboratory comparator — does this still hold? Replied, post #8 · Analytics › Method validation · 29 Aug 2024 · 4 likes I changed my mind about Relative retention time after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the…
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #13 · Compounds › Oral incretins · 28 Aug 2024 · 0 likes Worth separating two things that post #11 runs together. The claim about orforglipron upthread is stronger than its source supports. I have read the source. The source…
Where the four-week escalation interval comes from, and what it is not Replied, post #41 · Practice › Dosing & titration · 7 Jul 2024 · 14 likes This follows post #38 rather than contradicting it. Adding what did not work for me on four-week escalation interval, since the failures never get written up and they…